Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Centessa Pharmaceuticals
Biotech
Metabolic marketing master maneuvers to CEO—Chutes & Ladders
Metabolic marketing master maneuvers to CEO. Kyowa revamps leadership with historic CEO pick. Rebranded biotech launches with Seres CEO at helm.
Darren Incorvaia
,
Zoey Becker
Dec 12, 2025 8:30am
Centessa drops hemophilia B drug following Pfizer’s Hympavzi win
Nov 12, 2024 9:45am
Anaptys picks up rival to Biogen autoimmune asset from Centessa
Nov 28, 2023 6:30am
Elevated liver enzymes force Centessa to drop another asset
Aug 10, 2022 9:34am
Centessa dumps top program after evidence of tolerability issues
Jun 2, 2022 11:25am
Centessa hemophilia drug shows reduction of bleeding in phase 2
Sep 9, 2021 9:47am
